BZBiyun Zhang

Biyun Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Biyun Zhang has a total of 56 co-authors. Here are the top co-authors by number of shared publications:

  • Daoming Xu

    Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, China

    2 shared publications
  • Di Zhao

    Department of Radiation Oncology, Jiangsu Province Hospital of Chinese Medicine,Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, PR China

    2 shared publications
  • Hong Lu

    Department of Radiation Oncology, Jiangsu Province Hospital of Chinese Medicine,Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, PR China

    2 shared publications
  • Jing Liu

    Department of Acupuncture and Rehabilitation, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

    2 shared publications
  • Ling Bai

    Department of Nuclear Medicine, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

    2 shared publications
  • Xin Zhang

    Department of Acupuncture and Rehabilitation, Jiangsu Province Hospital of Chinese Medicine, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China

    2 shared publications

Latest Publications

  • Open Access

    Association between triglyceride-glucose index and femoral neck bone mineral density in women with breast cancer: a retrospective cross-sectional study

    by Jing Liu, Chihuan Huang, Di Zhang, Zun Wang, Jingyi Yang, Shaoxun Yuan, Xin Zhang, Jiangtao Wang, Ling Bai, Xuesheng Zhang, et al.

  • Wogonoside Suppresses the Self-renewal Ability of Glioma Stem Cells via Down-regulating AKT/ZEB1 Signaling Pathway

    by Biyun Zhang, Hong Lu, Yijun Wang, Di Zhao, Zhengyu Wu, Yuandong Cao

    Introduction: Glioma is the most prevalent primary central nervous system malignancy. Wogonoside, a flavonoid bioactive derived from Scutellaria baicalensis Georgi, has been reported to induce apoptosis in glioblastoma cells. However, the functional roles and molecular mechanisms in regulating glioma stem cell (GSC)-driven malignant progression remain poorly defined. The authors initially investigated the inhibitory effects of wogonoside on GSCs, as well as the intrinsic mechanisms responsible for these actions. Materials and methods: In vitro functional assays including extreme limiting dilution analysis, tumorsphere formation, tube formation, flow cytometry, immunofluorescence, and Western blotting were performed in primary human GSC lines (GSC#1 and GSC#2). RNA sequencing was applied to identify the key signaling pathways modulated by wogonoside. An orthotopic glioma mouse model was established to verify the in vivo antitumor efficacy of wogonoside. Results: Wogonoside significantly suppressed GSC self-renewal capacity, as evidenced by reduced tumor sphere number and size, decreased tumor-forming frequency, and downregulated the expression of GSC stemness markers SOX2 and CD133. Mechanistically, wogonoside inhibited the PI3K/AKT signaling pathway and enhanced ZEB1-mediated transcriptional repression in GSCs. Notably, ZEB1 rescue substantially reversed the inhibitory effects of wogonoside on GSC sphere formation and stemness marker expression, and restored the expression of ZEB1 target genes. Consistent with the in vitro findings, wogonoside markedly inhibited GSC-derived tumor growth and prolonged the survival of orthotopic glioma-bearing mice. Conclusion: This study reveals a novel antitumor mechanism of wogonoside in glioma, whereby it suppresses GSC stemness and malignant progression via PI3K/AKT inactivation and ZEB1-dependent transcriptional regulation. Wogonoside is a promising therapeutic candidate for the treatment of recurrent glioma.

  • Open Access

    Assessment of the effects of whole-body muscle and fat mass on bone mineral content based on 628 DXA datasets

    by Jing Liu, Dongpan Chen, Tanli Min, Ling Bai, Xin Zhang, Sheng Wang, Zun Wang, Mai Chen, Biyun Zhang, Daoming Xu

    Background: The prevalence of osteoporosis is steadily increasing. Although the relationships between muscle mass, fat mass, and bone mineral content (BMC) have been extensively studied, they remain contentious. This study aimed to develop a unified statistical model to evaluate the independent effects of total muscle and fat mass on BMC, clarify their respective roles in osteoporosis pathogenesis, and inform targeted prevention strategies. Methods: We retrospectively analyzed data from 628 subjects who underwent body composition assessment at the Affiliated Hospital of Nanjing University of Chinese Medicine between January 2022 and July 2024. Collected parameters included age, height, weight, body mass index (BMI), total BMC, total muscle mass, total fat mass, and whole-body bone mineral density (BMD) T-scores. Groups were compared by sex, age and whole-body BMD T-score categories. Spearman correlation and multiple linear regression analyses were used to assess the associations of total BMC with total muscle and total fat mass. Results: Males had greater height, weight, BMI, total BMC, total muscle mass, and whole-body T-scores than females ( P < 0.001), while females had higher total fat mass. Total muscle mass consistently showed a stronger positive correlation with total BMC than total fat mass across all subgroups. Multiple linear regression analysis confirmed total muscle mass was the strongest and stable independent positive correlate of total BMC(overall sample β= 0.687, P < 0.001). Total fat mass was positively associated with total BMC only in females, individuals >70 years, and osteoporosis patients, not in normal/osteopenic groups. Age negatively correlated with total BMC, especially in females ( β= -0.395, P < 0.001). BMI correlated with lower total BMC in the total sample, females, and osteopenia group. Conclusions: Muscle mass is the strongest and most consistent correlate of BMC. The role of fat is context-specific, varying by sex, age, and bone health. Based on current associative evidence, maintaining muscle may be considered a priority in bone health management, while fat’s impact requires individualized assessment. Clinical Trial Registration: http://www.chictr.org.cn/ identifier ChiCTR2400085209.

  • Open Access

    18F-FDG PET/CT detection of primary mammary-like adenocarcinoma of the vulva with multiple metastases: a case report

    by Qing Song, Biyun Zhang, Yu Gu

    Mammary-like adenocarcinoma of the vulva is a malignancy with a low incidence rate compared with the squamous cell carcinoma occurring at the same site. We present a rare case of mammary-like adenocarcinoma of the vulva with multiple-organ involvement using 18F-FDG PET/CT. This study indicates that 18F-FDG PET/CT can not only detect the primary lesion but also distinguish the stage of the mammary-like adenocarcinoma of the vulva.


  • Open Access

    Dihydroartemisinin Induces Ferroptosis in HCC by Promoting the Formation of PEBP1/15‐LO

    by Ying Su, Danli Zhao, Chun Jin, Zhanghao Li, Sumin Sun, Siwei Xia, Yuxin Zhang, Zili Zhang, Feng Zhang, Xuefen Xu, et al.

    Relevant researches have recognized the vital role of inducing ferroptosis in the treatment of tumor. The latest findings indicate that PEBP1/15‐LO can play an essential role in the process of cell death. However, its role in regulating ferroptosis in hepatocellular carcinoma (simplified by HCC) remains unclear. The previous research of our team has proved that DHA can induce ferroptosis of hepatic stellate cells. In this study, we found that DHA could also induce ferroptosis in HCC cells. Interestingly, DHA induced ferroptosis by promoting the formation of PEBP1/15‐LO and promoting cell membrane lipid peroxidation. In addition, we also found that DHA had no obvious regulatory effect on 15‐LO, but it could promote PEBP1 protein expression. Importantly, we discovered the upregulation of PEBP1 induced by DHA was related to the inhibition of its ubiquitination degradation. In vivo experiments have also obtained consistent results that DHA can inhibit tumor growth and affect the expression of ferroptosis markers in tumor tissues, which would be partially offset by interference with PEBP1.


  • Open Access

    Identification and validation a TGF-β-associated long non-coding RNA of head and neck squamous cell carcinoma by bioinformatics method

    by Teng Huang, Wei Huang, Hong Lu, Bi-Yun Zhang, Jun Ma, Di Zhao, Yi-Jun Wang, Da-Hai Yu, Xia He

    The role of transforming growth factorβ (TGF-β)-induced tumor progression in advanced malignancy is well established, but the involvement of long non-coding RNAs (lncRNAs) in TGF-β signaling remains unclear. This study aimed to identify TGF-β-associated lncRNAs in head and neck squamous cell carcinoma (HNSCC). Expression profiling of lncRNAs was obtained using Gene Expression Omnibus and The Cancer Genome Atlas. Real-time quantitative PCR was used to analyze the expression of EPB41L4A-AS2 in HNSCC cell line. We used bioinformatics resources (DAvID) to conduct Gene Ontology biological processes and KEGG pathways at the significant level. Wound healing assay, cell migration and invasion assays, were used to examine the effects of EPB41L4A-AS2 on tumor cell metastasis in vivo. Protein levels of EPB41L4A-AS2 targets were determined by western blot. A novel TGF-β-associated lncRNA, EPB41L4A-AS2, was found downregulated by TGF-β and associated with invasion and metastasis. The relationship of EPB41L4A-AS2 with the clinicopathological features and prognosis of HNSCC patients was evaluated. Bioinformatic analyses revealed that EPB41L4A-AS2 may be involved in processes associated with the tumor-associated signaling pathway, especially the TGF-β signaling pathway. Furthermore, a TGF-β-induced epithelial-to-mesenchymal transition (EMT) model was established. Low EPB41L4A-AS2 expression was determined, and overexpression of this gene inhibited cell migration and invasion in the EMT model. Moreover, EPB41L4A-AS2 suppressed TGFBR1 expression. EPB41L4A-AS2 might serve as a negative regulator of TGF-β signaling and as an effective prognostic biomarker and important target in anti-metastasis therapies of HNSCC patients.


  • Altered cortical activation during action observation in amyotrophic lateral sclerosis patients: a parametric functional MRI study

    by Haiqing Li, Yan Chen, Yuxin Li, Bo Yin, Weijun Tang, Xiangrong Yu, Weiyuan Huang, Daoying Geng, Biyun Zhang

    To investigate functional cerebral abnormalities in patients with amyotrophic lateral sclerosis (ALS) using functional magnetic resonance imaging (fMRI) during action observation. Thirty patients with ALS and 30 matched healthy controls underwent fMRI with an experimental paradigm while observing a video of repetitive flexion-extension of the fingers at three frequency levels or three complexity levels, alternated with periods of a static hand. A parametric analysis was applied to determine the effects of each of the two factors. Action observation activated similar neural networks as the research on execution of action in the ALS patients and healthy subjects in several brain regions related to the mirror-neuron system (MNS). In the ALS patients, in particular, the dorsal lateral premotor cortex (dPMC), inferior parietal gyrus (IPG), and SMA, were more activated compared with the activation in the controls. Increased activation within the primary motor cortex (M1), dPMC, inferior frontal gyrus (IFG), and superior parietal gyrus (SPG) mainly correlated with hand movement frequency/complexity in the videos in the patients compared with controls. The findings indicated an ongoing compensatory process occurring within the higher order motor-processing system of ALS patients, likely to overcome the loss of function. • Action observation activated similar core nodes of MNS in ALS and controls. • Increased activation within M1, dPMC, IFG and SPG mainly correlated with hand movement frequency/complexity. • Differences in patients and controls may be due to compensatory processes in ALS.


  • Solitary Fibrous Tumors of the Central Nervous System

    by Xiao-Qiang Wang, Qing Zhou, Shi-Ting Li, Chen-Long Liao, Hua Zhang, Bi-Yun Zhang

    Solitary fibrous tumor (SFT) is a rare mesenchymal neoplasm originating in the central nervous system (CNS), with imaging features currently not well known. The purposes were to describe and characterize clinical features and imaging findings of CNS SFT. We retrospectively reviewed computed tomographic (CT; n = 10) and magnetic resonance (MR) images (n = 18) of 22 patients with SFT (13 males and 9 females; mean, 47.6 years) with associated clinical records. Each lesion was found as a solitary, well-defined mass, ranging in size from 12 to 70 mm (mean, 38 mm). The tumor shape was roundlike in 16 cases (72.7%) and irregular in 6 cases (27.2%). The cerebellopontine angle zone was the most affected area (n = 6). On precontrast CT scans, 10 cases showed predominantly hyperattenuation (n = 9) and isoattenuation (n = 1). No lesion contained calcification, and 2 cases showed bone invasions. All 18 tumors examined by MR imaging showed homogeneous hypointensive (n = 5) or isointensive (n = 7) signal intensity and heterogeneous mixed isointense and hypointense signal intensity (n = 6) on T1-weighted images, whereas most tumors were predominantly isointense (n = 13) and hypointense (n = 4) to the cortex on T2-weighted images; on postcontrast CT and MR images, enhancement was marked homogeneous (n = 10) or heterogeneous (n = 12). Fourteen tumors had thickening of the meninges adjacent to the tumor. Although SFT is a rare neoplasm in the CNS, it should be considered in the differential diagnosis. The most affected area is the cerebellopontine angle zone. Solitary fibrous tumor tends to have some imaging features, such as high attenuation on CT, isointense to hypointense signal intensity on MR images, and marked enhancement.